Latest Breaking News On - Immunisation practices - Page 10 : comparemela.com

The World Health Organisation (WHO), yesterday, raised fresh safety concerns about Janssen and AstraZeneca vaccines. x A statement, by its Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on reports of Guillain-Barré Syndrome (GBS) following adenovirus vector COVID-19 vaccines, warned that vaccination with the Janssen and AstraZeneca jabs could cause rare immune system disorder that results in muscle weakness, pain, numbness and paralysis (GBS). Nigeria had, in March, received 3.92 million AstraZeneca doses and immunised over two million citizens. The GACVS, on July 13 and 20, 2021, met virtually to discuss rare reports of GBS following vaccination with the Janssen and AstraZeneca COVID-19 vaccines. Both jabs use an adenovirus platform as their backbone.

United statesChinwe ochuJohnson janssenChikwe ihekweazuUs advisory committee on immunisation practicesPharmacovigilance risk assessment committeeDrug administrationWorld health organisationGlobal advisory committee on vaccine safetyNigeria centre for disease controlEuropean medicines agencyGlobal advisory committeeVaccine safetyEuropean economic areaUnited states foodImmunisation practices